Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$59,085,289
+$26,185,006 QoQ
Shares Held
445,154
+13.9% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. APGE ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in APGE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,085,289 | 445,154 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $32,900,283 | 390,879 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24,710,338 | 327,376 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $11,302,508 | 284,483 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $11,473,682 | 264,188 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $11,748,895 | 314,478 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,826,326 | 327,292 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $18,006,687 | 306,549 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,245,836 | 311,203 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,544,684 | 324,224 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,939,036 | 176,773 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,432,239 | 161,138 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||